Catalyst Wire Dossier Catalyst Wire Dossier

LUMIZYME

ALGLUCOSIDASE ALFA · Genzyme Corporation
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for LUMIZYME, covering 2010-05-24 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)

See pricing